Payer perceptions on the use of economic models in oncology decision making

BACKGROUND: To support oncology formulary decisions, especially with accelerated regulatory approvals and niche populations, payers desire data beyond what regulators review. Economic models showing financial impact of treatments may help, but data on payers’ use of economic models in oncology are l...

Descripción completa

Detalles Bibliográficos
Autores principales: Biskupiak, Joseph, Oderda, Gary, Brixner, Diana, Burgoyne, Douglas, Arondekar, Bhakti, Niyazov, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390914/
https://www.ncbi.nlm.nih.gov/pubmed/34714111
http://dx.doi.org/10.18553/jmcp.2021.27.11.1560

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390914/
https://www.ncbi.nlm.nih.gov/pubmed/34714111
http://dx.doi.org/10.18553/jmcp.2021.27.11.1560

Ejemplares similares